Reaction
Stress Urinary Incontinence reporting signals
As of the last recalculation, Stress Urinary Incontinence appears in 1,072 FAERS reports alongside 15 co-occurring drug terms. The strongest observed disproportionality signal is ALENDRONATE SODIUM (PRR 50.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Alendronate Sodium | 212 | 50.6 | 50.7 |
| Theophylline Anhydrous | 21 | 33.5 | 33.6 |
| Tolterodine Tartrate | 15 | 32.9 | 33.0 |
| Theophylline | 19 | 32.7 | 32.7 |
| Mercaptopurine | 19 | 21.6 | 21.7 |
| Tiotropium Bromide Inhalation Spray | 12 | 21.0 | 21.0 |
| Vibegron | 8 | 19.5 | 19.5 |
| Lithium Carbonate | 16 | 18.6 | 18.6 |
| Oxybutynin Chloride | 8 | 17.8 | 17.9 |
| Estrogens, Conjugated | 38 | 12.8 | 12.9 |
| Conjugated Estrogens | 37 | 12.7 | 12.7 |
| Etonogestrel And Ethinyl Estradiol | 11 | 9.7 | 9.7 |
| Conjugated Estrogens And Medroxyprogesterone Acetate | 11 | 9.1 | 9.1 |
| Fesoterodine Fumarate | 5 | 9.0 | 9.0 |
| Copper | 8 | 3.6 | 3.6 |